Mangoceuticals (MGRX) Accumulated Depreciation & Amortization (2023 - 2025)
Mangoceuticals (MGRX) has disclosed Accumulated Depreciation & Amortization for 3 consecutive years, with $758.0 as the latest value for Q3 2025.
- Quarterly Accumulated Depreciation & Amortization fell 92.17% to $758.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $758.0 through Sep 2025, down 92.17% year-over-year, with the annual reading at $9936.0 for FY2024, 60.08% down from the prior year.
- Accumulated Depreciation & Amortization hit $758.0 in Q3 2025 for Mangoceuticals, up from $502.0 in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $24889.0 in Q4 2023 to a low of $250.0 in Q1 2025.
- Historically, Accumulated Depreciation & Amortization has averaged $8002.4 across 3 years, with a median of $6224.0 in 2024.
- Biggest five-year swings in Accumulated Depreciation & Amortization: rose 27.46% in 2024 and later crashed 95.98% in 2025.
- Year by year, Accumulated Depreciation & Amortization stood at $24889.0 in 2023, then plummeted by 60.08% to $9936.0 in 2024, then plummeted by 92.37% to $758.0 in 2025.
- Business Quant data shows Accumulated Depreciation & Amortization for MGRX at $758.0 in Q3 2025, $502.0 in Q2 2025, and $250.0 in Q1 2025.